- Investing Ideas
- Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Daiichi Sankyo Company
Market Cap: JP¥4.9t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,761.50
7D
3.2%
1Y
-24.2%
Sumitomo Pharma
Market Cap: JP¥576.9b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,286.00
7D
-3.2%
1Y
16.4%
GNI Group
Market Cap: JP¥164.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,499.00
7D
-4.0%
1Y
-18.7%
PeptiDream
Market Cap: JP¥122.6b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥954.40
7D
-4.5%
1Y
-43.4%
Nxera Pharma
Market Cap: JP¥85.3b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥921.00
7D
-2.3%
1Y
6.7%
SanBio
Market Cap: JP¥78.4b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥1,005.00
7D
-4.3%
1Y
-53.6%
Fuji Pharma
Market Cap: JP¥49.8b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,906.00
7D
-3.1%
1Y
37.6%
Heartseed
Market Cap: JP¥36.9b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,614.00
7D
-1.5%
1Y
-52.4%
Healios K.K
Market Cap: JP¥34.3b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥254.00
7D
-9.3%
1Y
-63.6%
StemRIM
Market Cap: JP¥18.4b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥294.00
7D
-3.0%
1Y
-3.9%
Kidswell Bio
Market Cap: JP¥7.2b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥145.00
7D
-8.2%
1Y
-50.7%
Noile-Immune Biotech
Market Cap: JP¥6.0b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥139.00
7D
0%
1Y
-22.3%
TMS
Market Cap: JP¥4.5b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥99.00
7D
-3.9%
1Y
-40.7%